Highest Price Target1
Lowest Price Target1
Consensus Price Target1
Analyst Rating Summary1
| Buy | Overweight | Hold | Underweight | Sell |
|---|---|---|---|---|
| 4 | 0 | 0 | 0 | 0 |
Analyst Firms Making Recommendations1
- Alliance Global Partners
- Ladenburg Thalmann
- Maxim Group
- JMP Securities
1calculated from analyst ratings published within the last 3 years
Analyst Ratings for Quoin Pharmaceuticals
date | ticker | Buy Now | Company | Current price | Upside/Downside | Analyst Firm | Analyst & % Accurate | Price Target Change | Rating Change | Previous / Current Rating | Get Alert |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 09/07/2022 | QNRX | Buy Now | Quoin Pharmaceuticals | $5.00 | 300% | Alliance Global Partners | James Molloy | → $240 | Initiates | → Buy | Get Alert |
| 05/06/2022 | QNRX | Buy Now | Quoin Pharmaceuticals | $5.00 | -60% | Ladenburg Thalmann | Aydin Huseynov | → $300 | Initiates | → Buy | Get Alert |
| 01/07/2022 | QNRX | Buy Now | Quoin Pharmaceuticals | $5.00 | — | Maxim Group | Naz Rahman | → $750 | Initiates | → Buy | Get Alert |
| 12/15/2021 | QNRX | Buy Now | Quoin Pharmaceuticals | $5.00 | 60% | JMP Securities | Jason Butler | — | Initiates | → Market Outperform | Get Alert |
What is the target price for Quoin Pharmaceuticals (QNRX)?
The latest price target for Quoin Pharmaceuticals (NASDAQ: QNRX) was reported by Alliance Global Partners on September 7, 2022. The analyst firm set a price target for $20.00 expecting QNRX to rise to within 12 months (a possible 300.00% upside). 0 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Quoin Pharmaceuticals (QNRX)?
The latest analyst rating for Quoin Pharmaceuticals (NASDAQ: QNRX) was provided by Alliance Global Partners, and Quoin Pharmaceuticals initiated their buy rating.
When is the next analyst rating going to be posted or updated for Quoin Pharmaceuticals (QNRX)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Quoin Pharmaceuticals, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Quoin Pharmaceuticals was filed on September 7, 2022 so you should expect the next rating to be made available sometime around September 7, 2023.
Is the Analyst Rating Quoin Pharmaceuticals (QNRX) correct?
While ratings are subjective and will change, the latest Quoin Pharmaceuticals (QNRX) rating was a initiated with a price target of $0.00 to $20.00. The current price Quoin Pharmaceuticals (QNRX) is trading at is $5.00, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.